Asston Pharmaceuticals Limited (BOM:544445)
India · Delayed Price · Currency is INR 107.53
+5.12 (5.00%)
At close: Oct 16, 2026
Asston Pharmaceuticals Revenue
In the fiscal year ending March 31, 2026, Asston Pharmaceuticals had annual revenue of 254.69M INR with 1.72% growth. Asston Pharmaceuticals had revenue of 100.53M in the half year ending March 31, 2026. That makes Asston Pharmaceuticals the 41,721st largest company in the world by revenue and 4,173rd in India.
Revenue
254.69M
Revenue Growth
+1.72%
P/S Ratio
4.61
Revenue / Employee
6.06M
Employees
42
Market Cap
1.17B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 254.69M | 4.30M | 1.72% |
| Mar 31, 2025 | 250.39M | 94.53M | 60.65% |
| Mar 31, 2024 | 155.86M | 90.48M | 138.39% |
| Mar 31, 2023 | 65.38M | -30.61M | -31.89% |
| Mar 31, 2022 | 95.99M | 15.64M | 19.47% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Parnax Lab | 2.52B |
| Lactose (India) | 1.71B |
| Aayush Wellness | 1.66B |
| Makers Laboratories | 1.49B |
| Godavari Drugs | 1.11B |
| Concord Drugs | 860.69M |
| Mercury Laboratories | 737.65M |
| Amwill Health Care | 454.92M |